Dishman Group appoints Mark Griffiths as CEO
Drug firm Dishman Pharmaceuticals and Chemicals today said Mark Griffiths has been appointed as Chief Executive Officer of Dishman Group of companies.
By PTI | Updated:
NEW DELHI: Drug firm Dishman Pharmaceuticals and Chemicals today said Mark Griffiths has been appointed as Chief Executive Officer of Dishman Group of companies.
"Griffiths is the CEO of Carbogen Amcis AG, Switzerland," Ahmedabad-based firm added in a filing to the BSE.
Griffiths has over 30 years of industrial experience in the pharmaceutical and fine chemical industry.
Switzerland-based Carbogen Amics AG which provides drug development and commercialisation services to the pharmaceutical and bio-pharmaceutical industries is an arm of Dishman Pharmaceuticals and Chemicals.
Shares of Dishman Pharmaceuticals and Chemicals today closed at Rs 55.40 per scrip on the BSE, down 2.64 per cent from its previous close.
"Griffiths is the CEO of Carbogen Amcis AG, Switzerland," Ahmedabad-based firm added in a filing to the BSE.
Griffiths has over 30 years of industrial experience in the pharmaceutical and fine chemical industry.
Switzerland-based Carbogen Amics AG which provides drug development and commercialisation services to the pharmaceutical and bio-pharmaceutical industries is an arm of Dishman Pharmaceuticals and Chemicals.
Shares of Dishman Pharmaceuticals and Chemicals today closed at Rs 55.40 per scrip on the BSE, down 2.64 per cent from its previous close.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
